Skip to content

Drug interactions

Ribociclib + Sofosbuvir-velpatasvir

Severity: Minor

Ribociclib and Sofosbuvir-velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ribociclib is a moderate CYP3A4 inhibitor, and velpatasvir is partly metabolised by CYP3A4 along with CYP2B6 and CYP2C8. Exposure to velpatasvir may rise slightly, but its wide safety margin makes this unlikely to matter clinically.

What this interaction means in plain words

Ribociclib and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ribociclib belongs to Oncology; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Ribociclib inhibits CYP3A4, which contributes to velpatasvir metabolism.

What to do

No dose adjustment is needed; monitor routinely for adverse effects of the hepatitis C regimen.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ribociclib and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ribociclib with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as minor. Ribociclib and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ribociclib is a moderate CYP3A4 inhibitor, and velpatasvir is partly metabolised by CYP3A4 along with CYP2B6 and CYP2C8. Exposure to velpatasvir may rise slightly, but its wide safety margin makes this unlikely to matter clinically.

How serious is the interaction between Ribociclib and Sofosbuvir-velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor routinely for adverse effects of the hepatitis C regimen.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in